RayanaAI
Account
TECH
HOLD / NEUTRALMeanRev
Composite
56.50
Technical
88.90
Fundamental
45.70
Rank
—
Price
71.90
Hurst
0.27
As of
Aug 7, 2026
Daily
Bio-Techne Corporation
HealthcareBiotechnology

Bio-Techne Corporation develops and manufactures biological reagents, diagnostic products, and analytical instruments for research, clinical diagnostics, and bioprocessing applications across various life science markets. Its Protein Sciences segment produces reagents such as antibodies, cytokines, and growth factors, along with protein analysis instruments for research and diagnostics. The Diagnostics and Spatial Biology segment offers diagnostic assays, tissue analysis tools, and quality control products for clinical laboratories and genomic research.

Market cap
$11.4B
P/E (trailing)
62.64
P/E (forward)
31.44
PEG ratio
2.17
Dividend yield
44.00%
Beta
1.30
52w range
43.20 – 72.75
Return on equity
+9.03%
Profit margin
+14.97%
Revenue growth
+1.30%
Earnings growth
—
Price history

1Y: 72.66 (+16.8%) · range 43.17–72.71

Cycle position
55/ 100 cycle scoreMID-BULL
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT

entry readiness 13 · NOT READY · exit proximity 0

Conviction
19/ 100 · maturity 0%
Buildup.335
EMA entry setup.4213
Fundamentals.2546
Volume profile
POC
72.45
Price vs POC
+0.3%
Overhead supply
5%
Runway
open sky

Value area 70.38–72.75 · 5% of 120d volume overhead · clean runway

Contributing sources

No source detections in the last 21 days.

Forward returns
HorizonReturnMFEState
20d+0.51%+0.74%mature
40d+0.65%+0.78%31/40d